Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, HONEYWELL INTERNATIONAL INC insiders sold a net $4.2M of stock across 26 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Nobody has filed for crossing 5%. That is a fact, not missing data.
HON planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
VIMAL KAPUR
Filed 2026-10-26
$1.4M
SU PING LU
Filed 2026-10-26
$650.9K
KENNETH WEST
Filed 2026-08-03
$76.8K
KENNETH WEST
Filed 2026-07-27
$4.2M
Government contracts
Award ceilings over the contract's life, subsidiaries included.
Not annual revenue (USASpending.gov).
Department Of Energy
IGF::CL,CT::IGF CONTRACT AWARD DE-NA0003525 TO THE NATIONAL TECHNOLOGY&ENGINEERING SOLUTIONS OF SAND · 2017-01-18
$43.5B
Department Of Energy
IGF::CL,CT::IGF MANAGEMENT AND OPERATION OF THE NATIONAL SECURITY CAMPUS -- CONTRACT NO. DE-NA000283 · 2015-07-09
$17.7B
National Aeronautics And Space Administration
IGF::CT::IGFMSOC FPDS-NG MISSION SYSTEMS OPERATIONS CONTRACT (MSOC) · 2018-01-02
$1.1B
National Aeronautics And Space Administration
GROUND SYSTEMS AND MISSION OPERATIONS (GSMO-3) · 2022-06-01
$681.6M
National Aeronautics And Space Administration
IGF::OT::IGF GROUND SYSTEMS AND MISSION OPERATIONS 2 (GSMO-2). THE PURPOSE OF THIS PROCUREMENT IS T · 2017-06-01
$506.6M
National Aeronautics And Space Administration
IGF::OT::IGF OTHER FUNCTIONS FILMSS WILL PROVIDE SUPPORT FOR MULTIPLE SUSTAINED PROJECT MANAGEMENT, · 2014-08-01
$364.7M
Federal awards ≥ $25M in the last 90 days, matched via the SAM.gov parent registry
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Honeywell International Inc. Technologies Public Affairs Council (Honpac)
Cycle 2026 · $5,893K spent
$5.9M
Federal Election Commission, matched by the PAC's connected organisation
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $4.2M sold by insiders over 180 days, 3 House member(s) bought in 12 months, disclosed weeks after the trade, $2.2M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Revenue, TTM HON
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
$36.7B
FY Dec 2022
$35.5B
FY Dec 2021
$34.4B
Sep 2026
$5.0B
Jun 2026
$9.7B
Mar 2026
$9.1B
Dec 2025
$9.8B
Sep 2025
$10.4B
Jun 2025
$10.4B
Mar 2025
$9.8B
Dec 2024
$9.2B
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM HON
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
+15.4%
FY Dec 2022
+14.0%
FY Dec 2021
+16.1%
Sep 2026
+13.3%
Jun 2026
+58.5%
Mar 2026
+9.0%
Dec 2025
-1.2%
Sep 2025
+17.5%
Jun 2025
+15.2%
Mar 2025
+14.8%
Dec 2024
+14.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
$967.0M
operating cash flow minus capex, 2025-10-01 to 2026-09-30
Free cash flow, TTM HON
FY Dec 2025
$5.4B
FY Dec 2024
$5.2B
FY Dec 2023
$4.6B
FY Dec 2022
$4.5B
FY Dec 2021
$5.1B
Sep 2026
$286.0M
Jun 2026
$961.0M
Mar 2026
-$873.0M
Dec 2025
$593.0M
Sep 2025
$3.3B
Jun 2025
$1.1B
Mar 2025
$407.0M
Dec 2024
$2.2B
At each fiscal year end
Single quarter
Debt to equity
0.74x
long-term 2026-09-30 plus current 2026-09-30; equity 2026-09-30
Debt to equity HON
FY Dec 2025
2.49x
FY Dec 2024
1.67x
FY Dec 2023
1.29x
FY Dec 2022
1.17x
FY Dec 2021
1.06x
Sep 2026
0.74x
Jun 2026
1.83x
Mar 2026
2.70x
Dec 2025
2.49x
Sep 2025
2.21x
Jun 2025
2.27x
Mar 2025
1.88x
Dec 2024
1.67x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.12x
TTM operating cash flow over long-term 2026-09-30 plus current 2026-09-30
Cash flow to debt HON
FY Dec 2025
0.19x
FY Dec 2024
0.20x
FY Dec 2023
0.26x
FY Dec 2022
0.27x
FY Dec 2021
0.31x
Sep 2026
0.12x
Jun 2026
0.15x
Mar 2026
0.14x
Dec 2025
0.19x
Sep 2025
0.20x
Jun 2025
0.17x
Mar 2025
0.19x
Dec 2024
0.20x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+36.0%
TTM net income over average of 2025-09-30 and 2026-09-30
Return on equity HON
FY Dec 2025
+29.1%
FY Dec 2024
+33.1%
FY Dec 2023
+34.8%
FY Dec 2022
+28.2%
FY Dec 2021
+30.7%
Sep 2026
+36.0%
Jun 2026
+47.4%
Mar 2026
+26.4%
Dec 2025
+29.1%
Sep 2025
+35.9%
Jun 2025
+34.6%
Mar 2025
+33.6%
Dec 2024
+33.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+10.5%
TTM net income over average of 2025-09-30 and 2026-09-30
Return on assets HON
FY Dec 2025
+6.4%
FY Dec 2024
+8.3%
FY Dec 2023
+9.1%
FY Dec 2022
+7.8%
FY Dec 2021
+8.6%
Sep 2026
+10.5%
Jun 2026
+10.5%
Mar 2026
+5.5%
Dec 2025
+6.4%
Sep 2025
+7.9%
Jun 2025
+7.7%
Mar 2025
+8.1%
Dec 2024
+8.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on invested capital HON
FY Dec 2025
n/a
FY Dec 2024
+15.6%
FY Dec 2023
n/a
FY Dec 2022
+23.2%
FY Dec 2021
n/a
Sep 2026
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
+12.0%
Jun 2025
+14.2%
Mar 2025
+15.5%
Dec 2024
+15.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employed HON
FY Dec 2025
n/a
FY Dec 2024
+15.8%
FY Dec 2023
n/a
FY Dec 2022
+18.4%
FY Dec 2021
n/a
Sep 2026
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
+10.8%
Jun 2025
+14.3%
Mar 2025
+14.8%
Dec 2024
+15.8%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.52x
close 2026-10-23 over four quarters of diluted EPS, 2025-10-01 to 2026-09-30
P/E, trailing HON
FY Dec 2025
16.17x
FY Dec 2024
25.64x
FY Dec 2023
24.47x
FY Dec 2022
29.14x
FY Dec 2021
26.02x
Sep 2026
10.04x
Jun 2026
9.08x
Mar 2026
20.23x
Dec 2025
16.17x
Sep 2025
14.07x
Jun 2025
20.48x
Mar 2025
24.06x
Dec 2024
25.64x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$81.1B
market value at close 2026-10-23 on 2026-09-30 shares, plus long-term 2026-09-30 plus current 2026-09-30, minus cash 2026-09-30
Enterprise value HON
FY Dec 2025
$152.2B
FY Dec 2024
$166.4B
FY Dec 2023
$149.2B
FY Dec 2022
$152.4B
FY Dec 2021
$150.5B
Sep 2026
$77.8B
Jun 2026
$96.2B
Mar 2026
$175.0B
Dec 2025
$152.2B
Sep 2025
$156.2B
Jun 2025
$172.3B
Mar 2025
$157.7B
Dec 2024
$166.4B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+1.4%
TTM free cash flow over market value at close 2026-10-23
FCF yield HON
FY Dec 2025
+4.2%
FY Dec 2024
+3.6%
FY Dec 2023
+3.4%
FY Dec 2022
+3.2%
FY Dec 2021
+3.6%
Sep 2026
+1.4%
Jun 2026
+5.7%
Mar 2026
+2.8%
Dec 2025
+4.2%
Sep 2025
+5.3%
Jun 2025
+3.7%
Mar 2025
+4.0%
Dec 2024
+3.6%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.25x
P/E over trailing EPS growth of 42%: four quarters to 2026-09-30 against the four to 2025-09-30
PEG, trailing HON
FY Dec 2025
0.36x
FY Dec 2024
9.05x
FY Dec 2023
1.48x
FY Dec 2022
n/a
FY Dec 2021
1.46x
Sep 2026
0.24x
Jun 2026
0.08x
Mar 2026
0.58x
Dec 2025
0.36x
Sep 2025
0.20x
Jun 2025
0.73x
Mar 2025
29.66x
Dec 2024
9.05x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
HON ranks highest on profitability (94th percentile) and institutional and government (65th), and lowest on insider conviction (21st), among Aerospace & Defense peers.
Profitability
94
Inputs
Return on equity+36.0% · 95 pct, sector of 41
Return on assets+10.5% · 94 pct, sector of 48
Return on invested capitalthe filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employedthe filed year and its quarters do not reconcile, so the trailing figure is withheld
Financial health
43
Inputs
Debt to equity0.74x · 24 pct, sector of 42
Cash flow to debt0.12x · 62 pct, sector of 38
Growth
22
Inputs
Revenue growth, YoY+7.8% · 36 pct, sector of 51
Backlog growth, YoY-51.9% · 7 pct, universe of 854
Insider conviction
21
Inputs
Net Form 4 buying (codes P and S), 180d-$4.2M · 42 pct, sector of 41
Insider buyers, 180d0 · 0 pct, sector of 41
Institutional and government
65
Inputs
Funds adding, latest quarterfewer than five funds report holding it
Congress net buyers, 365d0 · 40 pct, universe of 719
Federal contracts, 180d$41.0M · 59 pct, universe of 69
Lobbying spend, 4 quarters$10.7M · 97 pct, universe of 1,063
Risk and compliance
38
Inputs
Short interest, % of float+2.6% · 70 pct, sector of 61
Recalls per $1B revenue, 3y0.03 per $1B · 43 pct, universe of 292
EPA cases per $1B revenue, 5y0.40 per $1B · 0 pct, sector of 38
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HON filings, in plain words
Are Honeywell International insiders buying or selling HON?
In the 180 days to 2026-10-27, Honeywell International insiders were net sellers, a net $4.2M across purchases and sales reported on Form 4, by 1 seller.
Have members of Congress traded HON?
Yes. In the year to 2026-10-27, 3 House members disclosed buying HON and 3 House members disclosed selling it; the latest on record is a sale by Maria Elvira Salazar dated 2026-09-24.
Are there planned insider sales of HON?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $2.2M of stock; the latest, by VIMAL KAPUR, was filed 2026-10-26.
Read the full summary
In the 180 days to 2026-10-27, Honeywell International insiders were net sellers of HON, a net $4.2M across purchases and sales reported on Form 4 by 1 seller. None of the 7 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-27, 3 members of Congress disclosed buying HON and 3 members disclosed selling it; the latest on record is a sale by Maria Elvira Salazar dated 2026-09-24. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $2.2M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.